PC
CLPT icon

Pier Capital’s ClearPoint Neuro CLPT Stock Holding History

Pier Capital’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.97M Buy
+222,761
New +$2.78M 0.53% 88

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 37.36% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
CCM
Conway Capital Management Burbank, California $225M AUM 19.09% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Pier Capital's CLPT Position: Q2 2026 in Review

Pier Capital opened a new position in ClearPoint Neuro (CLPT) in Q2 2026: 222,761 shares worth $3.97M. The stake represents 0.53% of the portfolio and ranks #88 among its holdings.

45 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Pier Capital held 222,761 shares of ClearPoint Neuro worth $3.97M as of Q2 2026.
  • ClearPoint Neuro was a new Pier Capital position in Q2 2026.
  • ClearPoint Neuro made up 0.53% of Pier Capital's portfolio in Q2 2026, its #88 holding.
  • 45 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Pier Capital's 13F filing for Q2 2026, filed 5 Aug 2026.